Action PEPTONIC MEDICAL AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Peptonic Medical AB Nasdaq Stockholm

Actions

Cours en clôture Nasdaq Stockholm
Autres places de cotation
- SEK - Graphique intraday de Peptonic Medical AB
31/05 Peptonic Medical AB obtient un brevet en Europe pour le soulagement de la vulvodynie provoquée chez les femmes, le produit est prêt à être lancé CI
21/05 Peptonic Medical AB annonce des changements organisationnels CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Peptonic Medical: Peptonic announces outcome in the rights issue and the directed issue
Peptonic announces outcome in the rights issue and the directed issue
Peptonic Medical provides an operational update after the first 120 days with new CEO
Last day of trading with the unit rights in Peptonic
Peptonic Medical Secures European Patent for Treatment of Vulvodynia
Peptonic Medical AB granted patent in Europe for relief of provoked vulvodynia in women. Product ready for launch.
Peptonic Medical AB Grants Patent in Europe for Relief of Provoked Vulvodynia in Women, Product Ready for Launch
The subscription period in Peptonic's rights issue of units starts today
Peptonic publishes prospectus in connection with rights issue of units
PEPTONIC medical : Interim report Jan-March 2024
Peptonic Medical AB Announces Organizational Changes
Peptonic Medical AB Announces Organizational Changes
The board of Peptonic has decided to carry out a directed issue of units consisting of shares and warrants of series TO5
PEPTONIC medical : Updated year end report Jan-Dec 2023
PEPTONIC medical : Year end report Jan Dec 2023
Sweden’s Peptonic Medical Names New CFO
Jenni Björnulfson appointed as new CFO of Peptonic Medical
PEPTONIC medical AB Announces Chief Financial Officer Changes
Warrants of series TO4 were subscribed to approximately 1.80 percent and Peptonic receives approximately SEK 0.1 million
PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PMED
  4. Action
  5. Actualités Peptonic Medical AB
  6. Autres langues